Haemonetics Q2 Adj. EPS $1.35 Beats $1.29 Estimate, Sales $357.759M Beat $345.003M Estimate
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.29 by 4.65 percent. This is a 6.3 percent increase over earnings of $1.27 per share from the same
Haemonetics made more money than experts predicted this quarter. When a company beats its targets, it shows strong business and smart management.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.